Attached files

file filename
EX-99.2 - EXHIBIT 99.2 - CF Finance Acquisition Corp.s114716_ex99-2.htm
EX-99.1 - EXHIBIT 99.1 - CF Finance Acquisition Corp.s114716_ex99-1.htm
EX-10.7 - EXHIBIT 10.7 - CF Finance Acquisition Corp.s114716_ex10-7.htm
EX-10.6 - EXHIBIT 10.6 - CF Finance Acquisition Corp.s114716_ex10-6.htm
EX-10.5 - EXHIBIT 10.5 - CF Finance Acquisition Corp.s114716_ex10-5.htm
EX-10.4 - EXHIBIT 10.4 - CF Finance Acquisition Corp.s114716_ex10-4.htm
EX-10.3 - EXHIBIT 10.3 - CF Finance Acquisition Corp.s114716_ex10-3.htm
EX-10.2 - EXHIBIT 10.2 - CF Finance Acquisition Corp.s114716_ex10-2.htm
EX-10.1 - EXHIBIT 10.1 - CF Finance Acquisition Corp.s114716_ex10-1.htm
EX-4.1 - EXHIBIT 4.1 - CF Finance Acquisition Corp.s114716_ex4-1.htm
EX-3.1 - EXHIBIT 3.1 - CF Finance Acquisition Corp.s114716_ex3-1.htm
EX-1.2 - EXHIBIT 1.2 - CF Finance Acquisition Corp.s114716_ex1-2.htm
EX-1.1 - EXHIBIT 1.1 - CF Finance Acquisition Corp.s114716_ex1-1.htm

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): December 17, 2018 (December 12, 2018)

 

CF FINANCE ACQUISITION CORP. 

(Exact name of registrant as specified in its charter)

 

Delaware 001-38759 82-2657796
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)

 

110 East 59th Street, New York, NY 10022 

(Address of principal executive offices, including zip code)

 

Registrant’s telephone number, including area code: (212) 938-5000

 

Not Applicable
(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☑

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

 

 

 

 

 Item 1.01. Entry into a Material Definitive Agreement.

 

On December 12, 2018, CF Finance Acquisition Corp. (the “Company”) consummated its initial public offering (the “IPO”) of 25,000,000 units (the “Units”). Each Unit consists of one share of Class A common stock of the Company, par value $0.0001 per share (the “Class A Common Stock”), and three-quarters of one warrant of the Company (a “Warrant”), with each whole Warrant entitling the holder thereof to purchase one share of Class A Common Stock for $11.50 per share. Only whole warrants are exercisable. The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $250,000,000. The Company has granted Cantor Fitzgerald & Co. (“Cantor”), the representative of the several underwriters in the IPO, a 45-day option to purchase up to 3,750,000 additional Units to cover over-allotments, if any.

 

In connection with the IPO, the Company entered into the following agreements, forms of which were previously filed as exhibits to the Company’s Registration Statement on Form S-1 (File No. 333-228420) for the IPO, originally filed with the U.S. Securities and Exchange Commission (the “Commission”) on November 16, 2018 (as amended, the “Registration Statement”):

 

An Underwriting Agreement, dated December 12, 2018, by and among the Company, Cantor, as representative of the several underwriters, and the qualified independent underwriter named therein, a copy of which is attached as Exhibit 1.1 hereto and incorporated herein by reference.

 

A Business Combination Marketing Agreement, dated December 12, 2018, by and between the Company and Cantor, a copy of which is attached as Exhibit 1.2 hereto and incorporated herein by reference.

 

A Warrant Agreement, dated December 12, 2018, by and between the Company and Continental Stock Transfer & Trust Company, as warrant agent, a copy of which is attached as Exhibit 4.1 hereto and incorporated herein by reference.

 

A Letter Agreement, dated December 12, 2018, by and among the Company, its officers, its directors and CF Finance Holdings LLC (the “Sponsor”), a copy of which is attached as Exhibit 10.1 hereto and incorporated herein by reference.

 

An Investment Management Trust Agreement, dated December 12, 2018, by and between the Company and Continental Stock Transfer & Trust Company, as trustee, a copy of which is attached as Exhibit 10.2 hereto and incorporated herein by reference.

 

A Registration Rights Agreement, dated December 12, 2018, by and among the Company, the Sponsor and the holders party thereto, a copy of which is attached as Exhibit 10.3 hereto and incorporated herein by reference.

 

A Forward Purchase Contract, dated December 12, 2018, by and between the Company and the Sponsor, a copy of which is attached as Exhibit 10.4 hereto and incorporated herein by reference.

 

An Expense Reimbursement Agreement, dated December 12, 2018, by and between the Company and the Sponsor, a copy of which is attached as Exhibit 10.5 hereto and incorporated herein by reference.

 

A Sponsor Loan Note, dated December 12, 2018 (the “Sponsor Note”), issued to the Sponsor at the closing of the IPO, a copy of which is attached as Exhibit 10.6 hereto and incorporated herein by reference.

 

A Private Placement Units Purchase Agreement (the “Private Units Purchase Agreement”), dated December 12, 2018, by and between the Company and the Sponsor, a copy of which is attached as Exhibit 10.7 hereto and incorporated herein by reference.

 

 

 

 

Item 3.02. Unregistered Sales of Equity Securities.

 

Simultaneously with the closing of the IPO, pursuant to the Private Units Purchase Agreement, the Company completed the private sale of an aggregate of 600,000 units (the “Private Placement Units”) at a purchase price of $10.00 per Private Placement Unit, generating gross proceeds to the Company of $6,000,000. The Private Placement Units are identical to the Units sold as part of the Units in the IPO, except that the Sponsor has agreed not to transfer, assign or sell any of the Private Placement Units (except to certain permitted transferees) until 30 days after the completion of the Company’s initial business combination. The warrants underlying the Private Placement Units are also not redeemable by the Company so long as they are held by the Sponsor or its permitted transferees. In addition, for as long as the warrants underlying the Private Placement Units are held by the Sponsor, such warrants may not be exercised after five years from the effective date of the Registration Statement. No underwriting discounts or commissions were paid with respect to such sale. The issuance of the Private Placement Units was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended.

 

Item 5.03. Amendments to Certificate of Incorporation or Bylaws; Change in Fiscal Year.

 

On December 12, 2018, in connection with the IPO, the Company filed its Amended and Restated Certificate of Incorporation with Secretary of State of the State of Delaware, effective the same day. The terms of the Amended and Restated Certificate of Incorporation are set forth in the Registration Statement and are incorporated herein by reference. A copy of the Amended and Restated Certificate of Incorporation is attached as Exhibit 3.1 hereto and incorporated herein by reference.

 

Item 8.01. Other Events.

 

A total of $252,500,000, comprised of $244,000,000 of the proceeds from the IPO, $6,000,000 of the proceeds of the sale of the Private Placement Units and 2,500,000 of the proceeds from a loan by the Sponsor under the Sponsor Note, was placed in a U.S.-based trust account at J.P. Morgan Chase Bank, N.A., maintained by Continental Stock Transfer & Trust Company, acting as trustee. Except with respect to interest earned on the funds held in the trust account that may be released to the Company to pay its taxes, the funds held in the trust account will not be released from the trust account until the earliest of (i) the completion of the Company’s initial business combination, (ii) the redemption of any of the Company’s public shares properly submitted in connection with a stockholder vote to amend the Company’s amended and restated certificate of incorporation (a) to modify the substance or timing of its obligation to redeem 100% of the Company’s public shares if it does not complete its initial business combination within 18 months from the closing of the IPO or (b) with respect to any other provision relating to stockholders’ rights or pre-business combination activity, and (iii) the redemption of the Company’s public shares if it is unable to complete its initial business combination within 18 months from the closing of the IPO, subject to applicable law.

 

On December 12, 2018, the Company issued a press release announcing the pricing of the IPO, a copy of which is attached as Exhibit 99.1 to this Current Report on Form 8-K.

 

On December 17, 2018, the Company issued a press release announcing the closing of the IPO, a copy of which is attached as Exhibit 99.2 to this Current Report on Form 8-K.

 

 

 

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit No.   Description
1.1   Underwriting Agreement, dated December 12, 2018, by and among the Company, Cantor, as representative of the several underwriters, and the qualified independent underwriter named therein.
1.2   Business Combination Marketing Agreement, dated December 12, 2018, by and between the Company and Cantor.
3.1   Amended and Restated Certificate of Incorporation.
4.1   Warrant Agreement, dated December 12, 2018, by and between the Company and Continental Stock Transfer & Trust Company, as warrant agent.
10.1   Letter Agreement, dated December 12, 2018, by and among the Company, its officers, its directors and the Sponsor.
10.2   Investment Management Trust Agreement, dated December 12, 2018, by and between the Company and Continental Stock Transfer & Trust Company, as trustee.
10.3   Registration Rights Agreement, dated December 12, 2018, by and among the Company, the Sponsor and the holders party thereto.
10.4   Forward Purchase Contract, dated December 12, 2018, by and between the Company and the Sponsor.
10.5   Expense Reimbursement Agreement, dated December 12, 2018, by and between the Company and the Sponsor.
10.6   Sponsor Loan Note, dated December 12, 2018, issued to the Sponsor.
10.7   Private Placement Units Purchase Agreement, dated December 12, 2018, by and between the Company and the Sponsor.
99.1   Press Release, dated December 12, 2018.
99.2    Press Release, dated December 17, 2018. 

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  CF FINANCE ACQUISITION CORP.
     
  By: /s/ Howard W. Lutnick
    Name: Howard W. Lutnick
    Title:   Chief Executive Officer
     
Dated: December 17, 2018